OIP5-AS1 induced cisplatin resistance in osteosarcoma through regulating the LPAATβ/PI3K/AKT/mTOR signaling pathway via a mechanism involving miR-340-5p [23]. This evidence concerns the gene OIP5 and osteosarcoma.